Vivekanand Sharma1, Indra Neil Sarkar. 1. Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont 05405, USA.
Abstract
OBJECTIVE: To identify and highlight the feasibility, challenges, and advantages of providing a cross-domain pipeline that can link relevant biodiversity information for phyto-therapeutic assessment. MATERIALS AND METHODS: A public repository of clinical trials information (ClinicalTrials.gov) was explored to determine the state of plant-based interventions under investigation. RESULTS: The results showed that ≈ 15% of drug interventions in ClinicalTrials.gov were potentially plant related, with about 60% of them clustered within 10 taxonomic families. Further analysis of these plant-based interventions identified ≈ 3.7% of associated plant species as endangered as determined from the International Union for the Conservation of Nature Red List. DISCUSSION: The diversity of the plant kingdom has provided human civilization with life-sustaining food and medicine for centuries. There has been renewed interest in the investigation of botanicals as sources of new drugs, building on traditional knowledge about plant-based medicines. However, data about the plant-based biodiversity potential for therapeutics (eg, based on genetic or chemical information) are generally scattered across a range of sources and isolated from contemporary pharmacological resources. This study explored the potential to bridge biodiversity and biomedical knowledge sources. CONCLUSIONS: The findings from this feasibility study suggest that there is an opportunity for developing plant-based drugs and further highlight taxonomic relationships between plants that may be rich sources for bioprospecting.
OBJECTIVE: To identify and highlight the feasibility, challenges, and advantages of providing a cross-domain pipeline that can link relevant biodiversity information for phyto-therapeutic assessment. MATERIALS AND METHODS: A public repository of clinical trials information (ClinicalTrials.gov) was explored to determine the state of plant-based interventions under investigation. RESULTS: The results showed that ≈ 15% of drug interventions in ClinicalTrials.gov were potentially plant related, with about 60% of them clustered within 10 taxonomic families. Further analysis of these plant-based interventions identified ≈ 3.7% of associated plant species as endangered as determined from the International Union for the Conservation of Nature Red List. DISCUSSION: The diversity of the plant kingdom has provided human civilization with life-sustaining food and medicine for centuries. There has been renewed interest in the investigation of botanicals as sources of new drugs, building on traditional knowledge about plant-based medicines. However, data about the plant-based biodiversity potential for therapeutics (eg, based on genetic or chemical information) are generally scattered across a range of sources and isolated from contemporary pharmacological resources. This study explored the potential to bridge biodiversity and biomedical knowledge sources. CONCLUSIONS: The findings from this feasibility study suggest that there is an opportunity for developing plant-based drugs and further highlight taxonomic relationships between plants that may be rich sources for bioprospecting.
Authors: Justin Thomas Fischedick; Arno Hazekamp; Tjalling Erkelens; Young Hae Choi; Rob Verpoorte Journal: Phytochemistry Date: 2010-10-30 Impact factor: 4.072
Authors: David S Wishart; Craig Knox; An Chi Guo; Savita Shrivastava; Murtaza Hassanali; Paul Stothard; Zhan Chang; Jennifer Woolsey Journal: Nucleic Acids Res Date: 2006-01-01 Impact factor: 16.971
Authors: Harris A Lewin; Gene E Robinson; W John Kress; William J Baker; Jonathan Coddington; Keith A Crandall; Richard Durbin; Scott V Edwards; Félix Forest; M Thomas P Gilbert; Melissa M Goldstein; Igor V Grigoriev; Kevin J Hackett; David Haussler; Erich D Jarvis; Warren E Johnson; Aristides Patrinos; Stephen Richards; Juan Carlos Castilla-Rubio; Marie-Anne van Sluys; Pamela S Soltis; Xun Xu; Huanming Yang; Guojie Zhang Journal: Proc Natl Acad Sci U S A Date: 2018-04-24 Impact factor: 11.205
Authors: Oliver Gericke; Rachael M Fowler; Allison M Heskes; Michael J Bayly; Susan J Semple; Chi P Ndi; Dan Staerk; Claus J Løland; Daniel J Murphy; Bevan J Buirchell; Birger Lindberg Møller Journal: Plant J Date: 2021-09-16 Impact factor: 7.091